Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Avid_Radiopharmaceuticals> ?p ?o. }
Showing items 1 to 51 of
51
with 100 items per page.
- Avid_Radiopharmaceuticals abstract "Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, Pennsylvania. The company has developed a radioactive tracer called florbetapir (18F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease. Venture investors include Alta Partners, Osage University Partners, and Safeguard Scientifics.Eli Lilly and Company announced on November 8, 2010, that they would acquire Avid for $800 million, with $300 million paid out up front and the balance paid later on.".
- Avid_Radiopharmaceuticals locationCity Pennsylvania.
- Avid_Radiopharmaceuticals locationCity Philadelphia.
- Avid_Radiopharmaceuticals parentCompany Eli_Lilly_and_Company.
- Avid_Radiopharmaceuticals thumbnail Florbetapir_(18F)_skeletal.svg?width=300.
- Avid_Radiopharmaceuticals wikiPageExternalLink www.avidrp.com.
- Avid_Radiopharmaceuticals wikiPageExternalLink www.avidrp.com.
- Avid_Radiopharmaceuticals wikiPageID "27824553".
- Avid_Radiopharmaceuticals wikiPageRevisionID "596638773".
- Avid_Radiopharmaceuticals founder "Dr. Daniel Skovronsky".
- Avid_Radiopharmaceuticals hasPhotoCollection Avid_Radiopharmaceuticals.
- Avid_Radiopharmaceuticals homepage www.avidrp.com.
- Avid_Radiopharmaceuticals locationCity Pennsylvania.
- Avid_Radiopharmaceuticals locationCity Philadelphia.
- Avid_Radiopharmaceuticals locationCountry "United States".
- Avid_Radiopharmaceuticals name "Avid Radiopharmaceuticals".
- Avid_Radiopharmaceuticals parent Eli_Lilly_and_Company.
- Avid_Radiopharmaceuticals type "Private".
- Avid_Radiopharmaceuticals subject Category:Alzheimer's_disease.
- Avid_Radiopharmaceuticals subject Category:Companies_based_in_Philadelphia,_Pennsylvania.
- Avid_Radiopharmaceuticals subject Category:Companies_established_in_2005.
- Avid_Radiopharmaceuticals subject Category:Radiocontrast_agents.
- Avid_Radiopharmaceuticals type Abstraction100002137.
- Avid_Radiopharmaceuticals type CompaniesBasedInPhiladelphia,Pennsylvania.
- Avid_Radiopharmaceuticals type CompaniesEstablishedIn2005.
- Avid_Radiopharmaceuticals type Company108058098.
- Avid_Radiopharmaceuticals type Group100031264.
- Avid_Radiopharmaceuticals type Institution108053576.
- Avid_Radiopharmaceuticals type Organization108008335.
- Avid_Radiopharmaceuticals type SocialGroup107950920.
- Avid_Radiopharmaceuticals type YagoLegalActor.
- Avid_Radiopharmaceuticals type YagoLegalActorGeo.
- Avid_Radiopharmaceuticals type YagoPermanentlyLocatedEntity.
- Avid_Radiopharmaceuticals type Agent.
- Avid_Radiopharmaceuticals type Company.
- Avid_Radiopharmaceuticals type Organisation.
- Avid_Radiopharmaceuticals type Organization.
- Avid_Radiopharmaceuticals type Agent.
- Avid_Radiopharmaceuticals type SocialPerson.
- Avid_Radiopharmaceuticals type Thing.
- Avid_Radiopharmaceuticals comment "Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, Pennsylvania. The company has developed a radioactive tracer called florbetapir (18F).".
- Avid_Radiopharmaceuticals label "Avid Radiopharmaceuticals".
- Avid_Radiopharmaceuticals sameAs m.0cc8n9_.
- Avid_Radiopharmaceuticals sameAs Q4828783.
- Avid_Radiopharmaceuticals sameAs Q4828783.
- Avid_Radiopharmaceuticals sameAs Avid_Radiopharmaceuticals.
- Avid_Radiopharmaceuticals wasDerivedFrom Avid_Radiopharmaceuticals?oldid=596638773.
- Avid_Radiopharmaceuticals depiction Florbetapir_(18F)_skeletal.svg.
- Avid_Radiopharmaceuticals homepage www.avidrp.com.
- Avid_Radiopharmaceuticals isPrimaryTopicOf Avid_Radiopharmaceuticals.
- Avid_Radiopharmaceuticals name "Avid Radiopharmaceuticals".